Literature DB >> 8820902

Inhibition of tumor cell invasion and matrix degradation by aminopeptidase inhibitors.

H Fujii1, M Nakajima, T Aoyagi, T Tsuruo.   

Abstract

We investigated the effects of several types of aminopeptidase inhibitors on tumor cell-associated aminopeptidase activity and invasion. The aminopeptidase expressed by the human metastatic HT1080 fibrosarcoma cells was effectively suppressed by actinonin A, bestatin, leuhistin and matlystatin A, which are capable of inhibiting the purified aminopeptidase N, but not by arphamenine B specific for aminopeptidase B. The aminopeptidase N inhibitors inhibited HT1080 cells from degrading the subendothelial matrix and from invading into Matrigel in parallel with their aminopeptidase inhibitory activities. Matlystatin A, with multiple inhibitory activity against both aminopeptidase N and matrix metalloproteinases (MMP), was the most effective inhibitor of invasion. However, leuhistin and bestatin, without MMP inhibitory activity, also exhibited significant inhibition of invasion. The results suggest that aminopeptidase N plays a crucial role in the degradation and invasion of extracellular matrices by fibrosarcoma cells and that aminopeptidase inhibitors may be useful for preventing the spread of malignant tumors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8820902     DOI: 10.1248/bpb.19.6

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Inhibitors of polyamine biosynthesis decrease the expression of the metalloproteases meprin alpha and MMP-7 in hormone-independent human breast cancer cells.

Authors:  Gail L Matters; Andrea Manni; Judith S Bond
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

2.  Experimental evidence for a metallohydrolase mechanism in which the nucleophile is not delivered by a metal ion: EPR spectrokinetic and structural studies of aminopeptidase from Vibrio proteolyticus.

Authors:  Amit Kumar; Gopal Raj Periyannan; Beena Narayanan; Aaron W Kittell; Jung-Ja Kim; Brian Bennett
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

3.  Stromal aminopeptidase N expression: correlation with angiogenesis in non-small-cell lung cancer.

Authors:  Shinya Ito; Ryo Miyahara; Rei Takahashi; Shinjiro Nagai; Kazumasa Takenaka; Hiromi Wada; Fumihiro Tanaka
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-11-12

4.  CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells.

Authors:  D Fontijn; M C A Duyndam; M P A van Berkel; Y Yuana; L H Shapiro; H M Pinedo; H J Broxterman; E Boven
Journal:  Br J Cancer       Date:  2006-06-05       Impact factor: 7.640

5.  Synthesis of 3-N-sugar-substituted-2, 4(1H,3H)-quinazolinedionesas anti-angiogenesis agents.

Authors:  Conghai Huang; Xiangbao Meng; Jingrong Cui; Zhongjun Li
Journal:  Molecules       Date:  2009-07-08       Impact factor: 4.411

Review 6.  Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.

Authors:  Brigitte Bauvois; Daniel Dauzonne
Journal:  Med Res Rev       Date:  2006-01       Impact factor: 12.944

Review 7.  Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?

Authors:  Magdalena Mizerska-Dudka; Martyna Kandefer-Szerszeń
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-09-06       Impact factor: 4.291

8.  The Aminopeptidase CD13 Induces Homotypic Aggregation in Neutrophils and Impairs Collagen Invasion.

Authors:  Christine A Fiddler; Helen Parfrey; Andrew S Cowburn; Ding Luo; Gerard B Nash; Gillian Murphy; Edwin R Chilvers
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.